Braveheart Bio, Inc. (BRVE)

Braveheart Bio, Inc. (BRVE) is a healthcare company (biotechnology) based in the United States. The share price is $18.71, down 4.00% on the day, which values the company at $1.54B. Price as of 17 Nov 2026, 19:15 UTC, from Yahoo Finance.

Key facts

Share price
$18.71−4.00% today
Market value
$1.54B
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Braveheart Bio, Inc. in more detail

BRVE trades at -9.4× next year's expected earnings.

1 of the superinvestors tracked here hold BRVE, including Andrew Spokes (0.0% of the portfolio).

Superinvestors holding BRVE

1 of the investors tracked here report a position in their latest 13F filing.

Braveheart Bio, Inc. (BRVE): questions and answers

What is Braveheart Bio, Inc.'s market cap?

Braveheart Bio, Inc. is valued at $1.54B at a share price of $18.71.

Does BRVE pay a dividend?

Braveheart Bio, Inc. does not currently pay a regular dividend.

Which famous investors own BRVE?

In their latest quarterly filings, Andrew Spokes (0.0% of the portfolio) hold BRVE. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Braveheart Bio, Inc. (BRVE) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/BRVE

Underlying data: Yahoo Finance; company filings with the SEC.